Smith & Nephew PLC, Depuy Synthes (J&J), And Medtronic Are Dominating The Market For Global Orthopedic Soft Tissue Repair Market In 2016

Global Orthopedic Soft Tissue Repair Market is expected to reach USD 10,675.18 million by 2024 from USD 6,167.25 million in 2016, at a CAGR of 7.2%. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Access Full Report:- http://databridgemarketresearch.com/reports/global-orthopedic-soft-tissue-repair-market/

The global orthopedic soft tissue repair market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. The global orthopedic soft tissue repair market is dominated by Smith & Nephew PLC, Depuy Synthes (J&J), and Medtronic. Other players in this market include Arthrex, Inc, Zimmer Biomet, Stryker, Acelity L.P. Inc., Koninklijke DSM N.V., W. L. GORE & ASSOCIATES, INC; CONMED CORPORATION among others holds 11.1% of the global orthopedic soft tissue repair market in 2016.

SMITH & NEPHEW PLC:

Founded in 1856 and headquartered London, UK. Smith & Nephew PLC is the manufacturer of numerous medical devices, personal care products and advanced and latest along with the traditional wound care treatments. The company operates its business across the globe using these nine product categories such as knee implants, sports medicine joint repair, hip implants, arthroscopic enabling technologies, trauma & extremities, other surgical businesses, advanced wound care, advanced wound bioactives, and advanced wound devices. The product offered by the company comes under the trauma and extremities product category. The soft tissue category offers arthroscopy, carpel tunnel release, ligament repair, and TFCC repair.

Smith & Nephew has a presence in more than 100 countries across Africa, Americas, Asia, Australasia, Europe, and Middle East.

DEPUY SYNTHES (J&J):

Founded in 1886 and headquartered at New Brunswick, New Jersey, U.S., Depuy Synthes is a subsidiary of Johnson& Johnson Services, Inc. is engaged in the development and marketing of healthcare products. The company operates through three business segments, namely, Consumer, Pharmaceutical, and Medical Devices. The pharmaceutical segment offers a wide range of products for five major therapeutic applications—immunology, infectious diseases, neuroscience, oncology, and cardiovascular & metabolic diseases. The consumer segment of the company offers various products pertaining to baby care, oral care, skin care, women’s health, and wound care. The medical devices segment of the company offers various devices to be used in therapeutic areas such as orthopedic, surgical care, specialty surgery, cardiovascular care, diagnostics, diabetes care, and vision care.

DePuy Synthes, a subsidiary of Johnson& Johnson Services, Inc. offers the orthopedic soft tissue repair products.

Johnson & Johnson has more than 265 operating companies across the United States, Europe, Western Hemisphere, Africa, and Asia-Pacific. Some of its subsidiaries include Janssen Pharmaceuticals (Belgium), Ethicon Inc. (U.S.), Ethicon US LLC (U.S.), Neutrogena (U.S.), Synthes (Switzerland), Cordis Corporation (U.S.), LifeScan, Inc. (U.S.), Janssen-Cilag (U.S.), McNeil Consumer Healthcare (U.S.), Janssen Biotech, Inc. (U.S.), Ortho Clinical Diagnostics (U.S.), and Mentor Worldwide LLC (U.S.)

MEDTRONIC:

Founded in 1949 and headquartered Minneapolis, U.S. Medtronic is the world’s largest standalone medical technology development and a global healthcare solution company. The company operates in cardiac and vascular group (cardiac rhythm and heart failure, coronary and structural heart, aortic and peripheral vascular), minimally invasive therapies group (surgical solutions and patient monitoring & recovery), restorative therapies (spine, brain therapies, speciality therapies and pain therapies), and diabetes group (intensive insulin management, non- intensive diabetes therapies, diabetes service and solutions).

The company operates in more than 155 countries worldwide with more than 260 locations in research and development, manufacturing and distribution, and education centers. The company’s regional locations are Asia Pacific, Eastern Europe, Latin America, Middle East and Africa, Central Asia, South Asia, U.K., and Western Europe. Some of its subsidiaries include Medtronic Belgium S.A. /N.V. Belgium), Medtronic (Shanghai) Ltd. (China), Medtronic B.V. (Netherlands), and Medtronic Xomed Limited (U.K.)